# Diabetes Drug Eluting Sirolimus Stent Experience in Restenosis Trial

> **NCT00497172** · PHASE4 · COMPLETED · sponsor: **Cordis US Corp.** · enrollment: 150 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** CYPHER Sirolimus-eluting stent
- **DEVICE:** Bx SONIC bare metal stent

## Key facts

- **NCT ID:** NCT00497172
- **Lead sponsor:** Cordis US Corp.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-01
- **Primary completion:** 2006-03
- **Final completion:** 2009-04
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2010-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00497172

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00497172, "Diabetes Drug Eluting Sirolimus Stent Experience in Restenosis Trial". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00497172. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*